Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Palvella Therapeutics (PVLA) Q2 2025 Earnings
PVLA
15
May
Confirmed
Q4 2024
Q2 2025
-4
-2.91
-1.83
-0.74
Details
Expected EPS
-1.21125
Actual EPS
-0.74
Surprise EPS
0.47
Surprise Percent
+38.91%
Description
Palvella Therapeutics (PVLA) has reported earnings of -0.74 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login